Amgen (AMGN) Cash from Operations (2009 - 2026)

Amgen's Cash from Operations history runs 18 years deep, the most recent figure standing at 2189000000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 57.37% year-over-year to 2189000000.0; the TTM figure through Mar 2026 stood at 10756000000.0 (down 11.78% YoY), while the FY2025 annual figure was 9958000000.0, down 13.33% from the prior year.
• Cash from Operations was 2189000000.0 for Q1 2026 at Amgen, up from 1603000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 4771000000.0 in Q4 2024 to a low of 538000000.0 in Q4 2023.
• Historically, Cash from Operations has averaged 2460529411.76 across 5 years, with a median of 2280000000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations slumped 79.69% in 2023, then jumped 786.8% in 2024.
• A 5-year view of Cash from Operations shows it stood at 2649000000.0 in 2022, then plunged by 79.69% to 538000000.0 in 2023, then surged by 786.8% to 4771000000.0 in 2024, then plunged by 66.4% to 1603000000.0 in 2025, then jumped by 36.56% to 2189000000.0 in 2026.
• The last three Cash from Operations figures came in at 2189000000.0 (Q1 2026), 1603000000.0 (Q4 2025), and 4684000000.0 (Q3 2025), per Business Quant data.